NSE · JUBLINGREA
Jubilant Ingrevia Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,226 Cr with net profit ₹70 Cr — a 5.74% net margin, versus 10.08% the period before.
Shareholding
As of 2026-09-30
- Promoter45.22%
- Public22.67%
- FII6.94%
- DII25.17%
1,09,650 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.48× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #22 of 161 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,68,384 Cr | 74.39 | 21.93 | 29.5% | 17.7% |
| Pidilite Industries Ltd. | ₹1,60,827 Cr | 59.92 | 14.32 | 23.94% | 16.63% |
| SRF Ltd. | ₹72,932 Cr | 30.88 | 4.81 | 14.92% | 12.76% |
| Linde India Limited | ₹58,496 Cr | 118.36 | 13.32 | 11.26% | 18.08% |
| Gujarat Fluorochemicals Ltd. | ₹51,251 Cr | 75.18 | 6.1 | 7.97% | 11.43% |
| Navin Fluorine International Ltd. | ₹46,234 Cr | 50.46 | 10.36 | 20.41% | 22.4% |
| Godrej Industries Ltd. | ₹32,198 Cr | 26.32 | 2.88 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹28,667 Cr | 33.54 | 5.59 | 16.65% | 15.28% |
| Deepak Nitrite Ltd. | ₹20,917 Cr | 19.53 | 3.23 | 16.4% | 10.9% |
| Aether Industries Limited | ₹20,731 Cr | 82.24 | 7.99 | 9.61% | 19.21% |
| Jubilant Ingrevia Limited(this company) | ₹9,117 Cr | 25.33 | 2.75 | 10.57% | 7.19% |
AI analysis
AI-generated · google/gemini-2.5-flashJubilant Ingrevia Limited is listed with a market capitalization of Rs 11737 Cr. The company reported revenue of Rs 4215.43 Cr and a profit margin of 6.4%. Its P/E ratio is 134.71, and it has an EPS of Rs 18.06. The 52-week high for the share price was Rs 845.55, and the 52-week low was Rs 537.3.
Positives
- +Revenue grew 1% to Rs 4215.43 Cr annually.
- +The debt-to-equity ratio is 0.27, indicating low leverage.
- +The company maintains a dividend yield of 34%.
Negatives
- −Promoter shareholding decreased from 50.68% in March 2021 to 45.22% in June 2026.
- −9.3% of promoter shares are pledged as of June 30, 2026.
- −The profit margin is 6.4%, which is relatively thin.
- −The P/E ratio is 134.71, which is high.
Financial Performance
Jubilant Ingrevia Limited reported revenue of Rs 4215.43 Cr in the fiscal year ending March 2025, with a revenue growth rate of 1%. The company's net profit for the same period was Rs 251.182 Cr. Quarterly revenue for March 2026 was Rs 1178.65 Cr with a net profit of Rs 86.44 Cr. For the quarter ending December 2025, revenue was Rs 1050.91 Cr with a net profit of Rs 46.9 Cr.
Profitability & Returns
The company's profit margin stands at 6.4%. Return on equity (ROE) is 8.89%, and return on capital employed (ROCE) is 10.37%. The earnings per share (EPS) for the latest reported annual period is Rs 18.06. The company also offers a dividend yield of 34%.
Balance Sheet
Jubilant Ingrevia Limited maintains a debt-to-equity ratio of 0.27, indicating a relatively low reliance on debt financing. The book value per share is Rs 196.28.
Ownership & Pledges
As of June 30, 2026, promoter holding in Jubilant Ingrevia Limited was 45.22%. Foreign Institutional Investors (FIIs) held 6.49%, while Domestic Institutional Investors (DIIs) held 24.98%. Public shareholding was 23.30%. A total of 9.3% of promoter shares are pledged. The promoter shareholding has decreased from 50.68% in March 2021 to 45.22% in June 2026.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.